How to Navigate the AACR Annual Meeting as an Early-career Researcher
By AACR Associate Member Council members, 2025-2026 Attending the AACR Annual Meeting is a defining moment for early‑career researchers...
By AACR Associate Member Council members, 2025-2026 Attending the AACR Annual Meeting is a defining moment for early‑career researchers...
Key details about the program, registration, networking opportunities, and more, to help attendees prepare for the AACR Annual Meeting...
Takeaways from day four of the AACR Annual Meeting 2025 included data on one-dose HPV vaccination, technology advancing research,...
Takeaways from day three of the AACR Annual Meeting 2025 included the inspiring Opening Ceremony, a panel on cancer...
The second day of the AACR Annual Meeting 2025 included a 5K run/walk, the conclusion of the Educational Program,...
The AACR Annual Meeting 2025, held April 25-30, featured six Plenary Sessions that explored exciting areas of cancer research,...
Takeaways from the final day of the AACR Annual Meeting 2025 included the biggest discoveries presented, a look at...
The 11 early-career researchers selected as AACR NextGen Star 2025 explain how their area of cancer research could progress...
Special programs for high school and undergraduate students at the AACR Annual Meeting provide valuable opportunities for learning, networking,...
At the AACR Annual Meeting 2025, researchers and patient advocates shared insights into the impact of NIH funding cuts...
AACR Global Scholar-in-Training Award recipients shared how the program’s professional development opportunities have impacted their careers.
Past recipients of the AACR Global Scholar-in-Training Awards share how their experience with the program has been life-changing.
Takeaways from day 4 of the AACR Annual Meeting 2025 include declining breast cancer mortality, using liquid and tissue...
A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged...
Four past recipients of the Global Scholar-in-Training Award (GSITA) share how their experience at the AACR Annual Meeting impacted...
The New Drugs on the Horizon sessions at AACR Annual Meeting 2025 unveiled 12 novel cancer therapeutics and discussed...
AACR journals editors Robert Kruger and Elizabeth McKenna share how they're working to strengthen ties with the research...
Clinical trial results reported at the AACR Annual Meeting 2025 showcased new therapeutic approaches for non-small cell lung cancer....
The CheckPoints is a band comprised of cancer researchers, medical oncologists, and other professionals in the field of immuno-oncology.
A congressional forum hosted by Senators Tammy Baldwin and Peter Welch examined how NIH funding cuts could impact cancer...
At the AACR Annual Meeting 2025, researchers shared how AACR Project GENIE is helping provide insights into rare and...
Researchers are helping advance ovarian cancer care with breakthroughs that are reshaping treatment and early detection approaches.
In the second quarter of 2025, the FDA issued 13 new oncology approvals, including options for rare cancers, head...
At the AACR Annual Meeting 2025, a session on artificial intelligence in cancer care included ways of detecting skin...
Research unveiled at the AACR Annual Meeting 2025 highlighted advances in blood-based liquid biopsy tests to help improve cancer...
During the Presidential Select Symposium at the AACR Annual Meeting 2025, Patricia M. LoRusso, DO, PhD(h), FAACR, led a...
A single-cell atlas helped clarify diverse forms of acute myeloid leukemia, with potential implications for improving diagnostic, prognostic, and...
From July 1 to September 30, 2025, the FDA issued eight new oncology approvals, expanding treatment options for patients...
Researchers are exploring which cancer types have higher incidence in people under 50, what may be causing this rise...
Adding pembrolizumab before and after surgery to standard of care improved outcomes in patients with previously untreated head and...